Does a positive E. coli EIA mean I should treat with antibiotics?

Not automatically. A positive screen indicates antigen detection; pathotype confirmation is needed. Some E. coli infections (especially enterohaemorrhagic strains) can worsen with antibiotics, so culture, Shiga toxin testing, and clinical context guide treatment decisions.

When should Shiga toxin testing be ordered after a positive E. coli EIA?

Reflex to Shiga toxin assay in any patient with bloody diarrhoea or signs of haemolytic–uraemic syndrome, as enterohaemorrhagic E. coli (particularly O157:H7) produce Shiga toxin and require specific management and public-health reporting.

Can antibiotics affect the E. coli EIA result?

Yes. Antimicrobials reduce bacterial load and antigen shedding, so starting treatment before specimen collection can produce a false-negative result. Collect stool during the acute phase, ideally before antibiotics.

Is this test useful for asymptomatic patients?

No. Commensal E. coli are ubiquitous in stool, so the EIA is informative only in symptomatic individuals or during outbreak investigations. Screening asymptomatic patients will yield many false-positive signals without clinical relevance.

How does this add-on test differ from a full GI pathogen PCR panel?

The E. coli EIA is a single-analyte antigen screen appended to an existing stool order, cost-effective when E. coli is specifically suspected. A multiplex PCR panel simultaneously detects multiple bacteria, viruses, and parasites and can distinguish pathotypes by gene targets, but is more expensive.

What specimen handling is required for accurate results?

Collect stool in the kit provided by Genova, following volume and medium instructions. Refrigerate if shipping is delayed; most kits are designed for ambient transport within 72 hours. Delayed or improperly stored specimens may degrade antigen and reduce sensitivity.

How long does it take to receive results?

Approximately 5–7 business days from specimen receipt at Genova Diagnostics. Turnaround may align with the primary stool panel if ordered together.

BML-INF-075infectious diseaseUSA

Add-On: Escherichia coli EIA

Q: What is the difference between commensal and pathogenic E. coli?

Commensal E. coli are normal gut inhabitants present in everyone. Pathogenic strains carry virulence genes for toxins, adherence, or invasion, causing diarrhoeal illness. The EIA detects antigen but does not distinguish the two, so a positive result requires clinical correlation and typing assays.

The E. coli EIA is a stool antigen assay ordered as an add-on to comprehensive microbial panels in patients with acute or persistent diarrhoea. A positive result indicates E. coli antigen detection but does not distinguish pathogenic from commensal strains;

Biomarkers

Stool

Sample

5–7 business days

Turnaround

Fasting

What is the E. coli EIA test?

The Add-On Escherichia coli EIA is a qualitative or semi-quantitative enzyme immunoassay that detects E. coli antigens in stool. It is ordered as an adjunct to comprehensive stool panels or microbial ecology assessments when there is clinical suspicion of pathogenic E. coli infection — typically acute or persistent diarrhoea, particularly in travellers, young children, or patients with bloody stool. Because commensal E. coli are present in every healthy gut, a positive screen is only the starting point: practitioners use the result to guide further testing (culture, Shiga toxin assay, or PCR panels) that discriminates enteropathogenic from commensal strains. This is an add-on test, meaning it is appended to an existing stool collection rather than ordered as a standalone screen. It fits into the diagnostic cascade for infectious gastroenteritis, especially when standard bacterial culture has been non-revealing or when a provider wants broad antigen coverage before reflexing to more expensive molecular multiplex assays.

What does the E. coli EIA test measure?

E. coli Ag(Escherichia coli antigen)

Range: Negative; OD ratio <1.0 (method-specific threshold).Optimal: Negative. Asymptomatic carriage of commensal E. coli is universal; the test is informative only in symptomatic patients or outbreak settings where pathogenic strains are suspected.Qualitative (Positive/Negative) / Optical density (OD) ratio

Escherichia coli comprises a diverse group of gram-negative enteric bacteria, most strains of which are commensal inhabitants of the human gut. Pathogenic strains — including enterohaemorrhagic (EHEC), enterotoxigenic (ETEC), enteropathogenic (EPEC), enteroaggregative (EAEC), and enteroinvasive (EIEC) variants — possess virulence factors that cause diarrhoeal illness through toxin production, adherence, or invasion. Detection of E. coli antigen by enzyme immunoassay targets conserved or pathotype-specific antigens shed in stool during active infection.

A positive E. coli EIA indicates the presence of E. coli antigens in stool and may prompt further characterisation to identify the pathotype, particularly in cases of bloody diarrhoea (where EHEC and Shiga toxin testing are critical) or travellers' diarrhoea (commonly ETEC). Because commensal E. coli are ubiquitous in faeces, a positive qualitative screen must be interpreted alongside clinical presentation, stool characteristics, and complementary culture or molecular assays that discriminate pathogenic from non-pathogenic strains.

Why is the E. coli EIA test ordered?

Investigation of acute watery or bloody diarrhoea in travellers returning from regions where enterotoxigenic or enterohaemorrhagic E. coli are endemic
Evaluation of persistent diarrhoea in young children or infants, particularly when enteropathogenic E. coli (EPEC) is a differential
Outbreak investigation of foodborne or waterborne gastroenteritis where E. coli is a suspected source
Add-on screening in patients undergoing comprehensive stool microbiology or digestive-stool-analysis panels who present with infectious symptoms
Work-up of haemolytic–uraemic syndrome (HUS), where enterohaemorrhagic E. coli (especially O157:H7) is the leading bacterial cause and Shiga toxin testing must follow a positive screen
Assessment of post-infectious irritable bowel syndrome or dysbiosis when a preceding E. coli infection is suspected but was not confirmed at the acute presentation

Sample collection and turnaround

Sample type

Stool

Fasting required

Collection method

At-home collection kit

Turnaround

5–7 business days

Collection notes

Patient collects a stool specimen at home using the kit provided by Genova Diagnostics, which includes a specimen vial with stabilising medium or preservative. Instructions specify collection of a pea-sized sample or the volume indicated on the vial; the kit is then shipped to the laboratory at ambient temperature. Ideally, collect the specimen during the acute phase before antibiotics are started, to maximise antigen detection.

Specimen requirements

Fresh stool, unpreserved or in the supplied transport medium. Follow the kit's instructions for specimen volume and handling. Refrigerate after collection if there will be a delay in shipping; most Genova kits are designed for ambient transport within 72 hours.

What can affect E. coli EIA results?

reducesAntibiotic therapy before specimen collection

Antimicrobials reduce bacterial load and may clear antigen shedding, yielding false-negative results if the sample is collected after treatment has begun; pre-treatment specimens are preferred.

variableStool consistency and specimen handling

Very dilute or watery stool may reduce antigen concentration below assay sensitivity; delay in transport or inadequate refrigeration can degrade labile antigens, although most EIAs are designed for room-temperature-stable specimens.

elevatesPresence of commensal E. coli

All human stool contains commensal E. coli, so antigen assays that do not distinguish pathogenic from non-pathogenic strains will produce positive signals in many samples; clinical correlation and follow-on typing are essential.

variableCross-reactivity with related enteric organisms

Some E. coli EIA platforms show minor cross-reactivity with other Enterobacteriaceae; specificity varies by assay design, and discordant results should be resolved by culture or molecular methods.

variableTiming of specimen collection relative to symptom onset

Antigen shedding is highest during the acute phase; specimens collected very early (before peak shedding) or late (after immune clearance) may miss the diagnostic window.

What do E. coli EIA results mean?

Elevated

A positive or elevated OD ratio indicates detection of E. coli antigen and warrants follow-on testing to identify the pathotype. In the setting of bloody diarrhoea, reflex to Shiga toxin EIA and culture for O157:H7; in travellers' watery diarrhoea, consider ETEC-specific assays. A positive screen in an asymptomatic patient or in the absence of supporting clinical or stool findings (mucus, blood, leucocytes) is more likely to reflect commensal carriage and should not be treated without further confirmation.

Normal

A negative result makes E. coli an unlikely cause of the current illness, though it does not exclude early infection (before peak shedding), post-treatment clearance, or infection with a pathogen not detected by this assay. Serial or paired specimens and correlation with other stool studies (culture, ova and parasites, viral panels) are often needed.

Reduced

Not applicable; the assay is qualitative or semi-quantitative and does not report low-positive or suppressed values.

Note: Because commensal E. coli are universal in stool, a positive EIA screen is not diagnostic of pathogenic infection without clinical correlation, stool characteristics (blood, mucus, faecal leucocytes), and confirmatory typing (culture, toxin assay, or PCR). The test is informative only in symptomatic patients or outbreak settings, and a negative result does not rule out non-E. coli causes of gastroenteritis.

Frequently asked questions

Commensal E. coli are normal gut inhabitants present in everyone. Pathogenic strains carry virulence genes for toxins, adherence, or invasion, causing diarrhoeal illness. The EIA detects antigen but does not distinguish the two, so a positive result requires clinical correlation and typing assays.

How to access the E. coli EIA test

The E. coli EIA reference page is free and open to all practitioners. Create a free practitioner account to see pricing, save tests to your list, and generate requisition forms. Verification takes 1–2 business days.

Create Free Account

About this page

Published: October 7, 2026

Last reviewed: October 7, 2026

References:

Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev. (1998)
Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet. (2005)
Shane AL, et al. Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. (2017)
Riddle MS, et al. ACG clinical guideline: diagnosis, treatment, and prevention of acute diarrheal infections in adults. Am J Gastroenterol. (2016)

This content is for licensed healthcare practitioners only and does not constitute medical advice. Clinical decisions should be based on the full clinical picture and not on any single test result.